IFG
REGN icon

Independent Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Independent Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$679K Sell
1,089
-1
-0.1% -$681 0.01% 846
2026
Q1 		$842K Sell
1,090
-97
-8% -$74.3K 0.02% 688
2025
Q4 		$916K Buy
1,187
+198
+20% +$134K 0.02% 651
2025
Q3 		$556K Sell
989
-37
-4% -$20.9K 0.01% 802
2025
Q2 		$539K Sell
1,026
-3
-0.3% -$1.67K 0.01% 749
2025
Q1 		$653K Buy
1,029
+200
+24% +$138K 0.02% 614
2024
Q4 		$591K Buy
829
+21
+3% +$17.6K 0.02% 634
2024
Q3 		$849K Sell
808
-13
-2% -$14.5K 0.03% 489
2024
Q2 		$863K Buy
821
+2
+0.2% +$1.94K 0.03% 438
2024
Q1 		$788K Buy
819
+52
+7% +$49.4K 0.04% 445
2023
Q4 		$674K Sell
767
-95
-11% -$78.2K 0.04% 470
2023
Q3 		$709K Buy
862
+152
+21% +$119K 0.05% 405
2023
Q2 		$510K Buy
710
+10
+1% +$7.71K 0.04% 479
2023
Q1 		$575K Sell
700
-67
-9% -$50.5K 0.05% 416
2022
Q4 		$553K Buy
767
+201
+36% +$148K 0.05% 389
2022
Q3 		$390K Hold
566
– – 0.04% 460
2022
Q2 		$335K Sell
566
-32
-5% -$20.8K 0.04% 472
2022
Q1 		$418K Buy
598
+56
+10% +$35.4K 0.03% 486
2021
Q4 		$342K Sell
542
-243
-31% -$149K 0.03% 543
2021
Q3 		$475K Buy
785
+224
+40% +$139K 0.05% 378
2021
Q2 		$313K Sell
561
-50
-8% -$25.3K 0.03% 521
2021
Q1 		$289K Buy
611
+10
+2% +$4.87K 0.04% 482
2020
Q4 		$290K Hold
601
– – 0.04% 432
2020
Q3 		$336K Sell
601
-538
-47% -$326K 0.06% 326
2020
Q2 		$710K Buy
1,139
+332
+41% +$188K 0.16% 162
2020
Q1 		$394K Buy
+807
New +$333K 0.12% 210

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Independent Financial Group's REGN Position: Q2 2026 in Review

Independent Financial Group reduced its Regeneron Pharmaceuticals (REGN) stake by 0.09% in Q2 2026, selling an estimated $681 and leaving 1,089 shares worth $679K. The position accounts for 0.01% of the portfolio, ranked #846.

Independent Financial Group first reported a position in REGN in Q1 2020 and has held it in 26 quarters since. The position peaked at $916K in Q4 2025. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Independent Financial Group held 1,089 shares of Regeneron Pharmaceuticals worth $679K as of Q2 2026.
  • Independent Financial Group sold 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
  • Regeneron Pharmaceuticals made up 0.01% of Independent Financial Group's portfolio in Q2 2026, its #846 holding.
  • Independent Financial Group first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Independent Financial Group's Regeneron Pharmaceuticals position peaked at $916K in Q4 2025.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.